Fresenius Medical Care AG (FMS) Cash from Financing Activities (2009 - 2026)

Fresenius Medical Care AG's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$510.5 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 249.72% year-over-year to -$510.5 million; the TTM figure through Mar 2026 stood at -$2.0 billion (up 23.53% YoY), while the FY2025 annual figure was -$1.6 billion, up 40.51% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$510.5 million, down from -$242.6 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $89.7 million in Q2 2025, with the low at -$1.3 billion in Q3 2025.
• The 5-year median for Cash from Financing Activities is -$506.7 million (2022), against an average of -$507.5 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities tumbled 14656.63% in 2024, then surged 109.94% in 2025.
• Fresenius Medical Care AG's Cash from Financing Activities stood at -$122.3 million in 2022, then slumped by 555.76% to -$802.3 million in 2023, then retreated by 28.56% to -$1.0 billion in 2024, then surged by 76.48% to -$242.6 million in 2025, then tumbled by 110.47% to -$510.5 million in 2026.
• Business Quant data shows FMS's Cash from Financing Activities at -$510.5 million in Q1 2026, -$242.6 million in Q4 2025, and -$1.3 billion in Q3 2025.